Signaling Pathways - eIF4E/eIF3G interaction - P97 ATPase - Adenosine A2A Receptors - Calcium-Activated Potassium (KCa) Channels
清除全部
- B5904 Regadenoson1 Citation中文名: 类伽腺苷Target: Adenosine A2A ReceptorsSummary: A2A腺苷受体激动剂
- B6995 SCH 58261Target: Adenosine A2A ReceptorsSummary: A2A腺苷受体竞争性拮抗剂
- B3696 4EGI-12 CitationTarget: eIF4E/eIF3G interactionSummary: 竞争性的eIF4E/eIF4G相互作用抑制剂。
- B2191 Dequalinium Chloride中文名: 地喹氯铵Target: PKC|Calcium-Activated Potassium (KCa) ChannelsSummary: PKC抑制剂
- A8629 DBeQTarget: P97 ATPaseSummary: P97 ATP酶抑制剂
- A8454 Istradefylline (KW-6002)中文名: 伊曲茶碱Target: Adenosine A2A ReceptorsSummary: 选择性A2A受体拮抗剂
- A5354 Zonisamide中文名: 唑尼沙胺Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Carbonic Anhydrases|Calcium-Activated Potassium (KCa) ChannelsSummary: 抗惊厥和机械效应的抗癫痫药
- A1888 TRAM-34Target: Calcium-Activated Potassium (KCa) ChannelsSummary: KCa3.1阻断剂
- A3885 TozadenantTarget: Adenosine A2A ReceptorsSummary: 腺苷2A受体拮抗剂
- A3735 PreladenantTarget: Adenosine A2A ReceptorsSummary: 腺苷A2A受体拮抗剂